Tg Therapeutics Inc (TGTX)

SG&A Expense Growth

50.38%

Fiscal year · Period ending:

TGTX logo

TGTX SG&A Expense Growth

Latest reported50.38%
TGTX FY SG&A Growth (YoY) (0.00% → 50.38%)
High-resolution chart · PNG

TGTX sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
50.3804%
25.7461%
28.5095%
-25.4555%
18.7668%
617.7081%
-0.8838%
-7.1643%
65.1431%
-36.7111%
-1.0258%
137.1119%
39.2482%
762.0035%
-63.5298%
-12.1443%
-33.6689%
-27.6687%
-5.7273%
67.0572%
15.1416%
11.4076%
18.0362%
-46.9069%
-12.4597%
71.3507%
-29.6296%
-3.5714%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.